5451 - 5460 of 8471 Results
Title
Year
- Miro1 Marks Parkinson’s Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson’s Models2019OPENTitle: Miro1 Marks Parkinson’s Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson’s ModelsJournal Name: Cell MetabolismPublisher: Elsevier BVVol: 30Issue #: 6Start Page: 1131End Page: 1140.e7Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.cmet.2019.08.023Best OA location URL: http://www.cell.com/article/S1550413119304978/pdfCitation Count: 134
- Apoptosis signal regulating kinase 1 deletion mitigates α-synuclein pre-formed fibril propagation in mice2019OPENTitle: Apoptosis signal regulating kinase 1 deletion mitigates α-synuclein pre-formed fibril propagation in miceJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 85Issue #:Start Page: 49End Page: 57Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.09.012Best OA location URL: https://europepmc.org/articles/pmc7064162?pdf=renderCitation Count: 14
- Feasibility and utility of a clinician dashboard from wearable and mobile application Parkinson’s disease data2019OPENTitle: Feasibility and utility of a clinician dashboard from wearable and mobile application Parkinson’s disease dataJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-019-0169-yBest OA location URL: https://www.nature.com/articles/s41746-019-0169-y.pdfCitation Count: 57
- Levels of Oligomeric α-Synuclein in Reflex Tears Distinguish Parkinson'S Disease Patients From Healthy Controls2019OPENTitle: Levels of Oligomeric α-Synuclein in Reflex Tears Distinguish Parkinson'S Disease Patients From Healthy ControlsJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 13Issue #: 17Start Page: 1447End Page: 1457Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/bmm-2019-0315Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/bmm-2019-0315Citation Count: 32
- Physiotherapy improves motor function in patients with the Parkinson variant of multiple system atrophy: A prospective trial2019RESTRICTEDTitle: Physiotherapy improves motor function in patients with the Parkinson variant of multiple system atrophy: A prospective trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 67Issue #:Start Page: 60End Page: 65Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.09.026Citation Count: 31
- Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs2019OPENTitle: Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial DesignsJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 107Issue #: 3Start Page: 553End Page: 562Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpt.1634Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7939141Citation Count: 17
-
OPENTitle: Machine learning for comprehensive forecasting of Alzheimer’s Disease progressionJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-019-49656-2Best OA location URL: https://www.nature.com/articles/s41598-019-49656-2.pdfCitation Count: 167
- Quadruple Decision Making for Parkinson’s Disease Patients: Combining Expert Opinion, Patient Preferences, Scientific Evidence, and Big Data Approaches to Reach Precision Medicine2019OPENTitle: Quadruple Decision Making for Parkinson’s Disease Patients: Combining Expert Opinion, Patient Preferences, Scientific Evidence, and Big Data Approaches to Reach Precision MedicineJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 10Issue #: 1Start Page: 223End Page: 231Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191712Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191712?id=journal-of-parkinsons-disease%2Fjpd191712Citation Count: 28
- How to evaluate effects of occupational therapy – lessons learned from an exploratory randomized controlled trial2019RESTRICTEDTitle: How to evaluate effects of occupational therapy – lessons learned from an exploratory randomized controlled trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 67Issue #:Start Page: 42End Page: 47Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.09.013Citation Count: 4
- Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment2019RESTRICTEDTitle: Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairmentJournal Name: Human Brain MappingPublisher: WileyVol: 40Issue #: 18Start Page: 5424End Page: 5442Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/hbm.24782Best OA location URL: https://europepmc.org/articles/pmc6864887?pdf=renderCitation Count: 130